Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
The new offering works in tandem with the expansion of Better Care Services' options to provide a suite of solutions for individuals taking GLP-1s
McFadden said the results of the study could help guide the development of targeted communication strategies, enhance product positioning and help design complementary lifestyle recommendations for patients using GLP-1 treatments
The UBC study analyzed insurance claim records from 20062020 for about 16 million US patients who had been prescribed semaglutide or liraglutidethe two main active ingredients in GLP-1sor bupropion-naltrexone to see how many patients from each group developed a gastrointestinal condition
These results are comparable to some bariatric procedures and far exceed the two to five percent typical of lifestyle interventions or older medications
GLP-1 receptor agonists, the drug class that includes Ozempic, Wegovy, and Mounjaro, were originally developed to treat type 2 diabetes
US$ 21.88
US$ 27.90
US$ 29.80
US$ 29.31
US$ 21.31
